Loomis, Sayles & Company’s Y-mAbs Therapeutics YMAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-782,084
| Closed | -$23.7M | – | 928 |
|
|
2021
Q1 | $23.7M | Sell |
782,084
-2,198
| -0.3% | -$66.5K | 0.03% | 269 |
|
|
2020
Q4 | $38.8M | Sell |
784,282
-4,654
| -0.6% | -$230K | 0.05% | 166 |
|
|
2020
Q3 | $30.3M | Buy |
788,936
+14,949
| +2% | +$574K | 0.04% | 169 |
|
|
2020
Q2 | $33.4M | Buy |
773,987
+67,072
| +9% | +$2.9M | 0.05% | 143 |
|
|
2020
Q1 | $18.5M | Buy |
706,915
+161,859
| +30% | +$4.22M | 0.04% | 178 |
|
|
2019
Q4 | $17M | Buy |
+545,056
| New | +$17M | 0.03% | 248 |
|